Eligibility criteria for tirzepatide (Mounjaro®)
Tirzepatide will not be accessible to everyone who wishes to use it. People with the highest health risks and who meet the clinical criteria will be prioritised. Full qualifying clinical criteria is a BMI (Body Mass Index) of 40 or more plus four or more of the following diagnosed health conditions:
- Type 2 diabetes
- High blood pressure
- Heart disease
- Obstructive sleep apnoea
- Abnormal blood fats (dyslipidaemia)
Access to the drug must be accompanied by wraparound care which will include support for people to make dietary changes and to increase physical activity. Tirzepatide will not be prescribed as a standalone treatment, and patients must fully participate with the wraparound support programme. The programme will not be fullfilled by GP's until later in the year so for now you will be referred to the Weight Management Team in this area.
Please do not contact us unless you have a BMI over 40 and have 4 out of the 5 conditions listed above.
If you fit the criteria and are interested in starting tirzepatide, then please contact the Surgery.
NHS Mid and South Essex ICB has provided information on tirzepatide on its website - Visit the website for more information.